n-methyl-3,4-methylenedioxyamphetamine has been researched along with fluorodeoxyglucose f18 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arning, C; Büll, U; Gouzoulis-Mayfrank, E; Kaiser, HJ; Sabri, O; Sass, H; Schreckenberger, M; Schulz, G; Tuttass, T; Wagenknecht, G | 1 |
| Beyer, W; Buchert, R; Obrocki, J; Schiemann, T; Thomasius, R; Väterlein, O | 1 |
| Bohuslavizki, KH; Buchert, R; Clausen, M; Jenicke, L; Obrocki, J; Petersen, K; Thomasius, R; Väterlein, O | 1 |
| Andresen, B; Buchert, R; Obrocki, J; Petersen, K; Schmoldt, A; Thomasius, R | 1 |
| Arango, C; Desco, M; García-Barreno, P; Ricaurte, G; Soto-Montenegro, ML; Vaquero, JJ | 1 |
| Biersack, HJ; Bosch, OG; Jessen, F; Joe, A; Kühn, KU; Maier, W; Quednow, BB; Seifritz, E; Wagner, M | 1 |
2 trial(s) available for n-methyl-3,4-methylenedioxyamphetamine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study].
Topics: Administration, Oral; Adult; Brain; Brain Mapping; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Hallucinogens; Humans; Magnetic Resonance Imaging; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Specific neurotoxicity of chronic use of ecstasy.
Topics: Adolescent; Adult; Brain; Female; Fluorodeoxyglucose F18; Glucose; Hallucinogens; Humans; Linear Models; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Tomography, Emission-Computed | 2002 |
4 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography.
Topics: Adult; Case-Control Studies; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Glucose; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Tomography, Emission-Computed | 1999 |
Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
Topics: Adolescent; Adult; Biological Transport; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Hallucinogens; Humans; Isoquinolines; Kinetics; Male; N-Methyl-3,4-methylenedioxyamphetamine; Radiopharmaceuticals; Receptors, Serotonin; Regression Analysis; Serotonin Antagonists; Substance-Related Disorders; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 2001 |
Effects of MDMA on blood glucose levels and brain glucose metabolism.
Topics: Adrenergic Uptake Inhibitors; Amygdala; Animals; Auditory Cortex; Blood Glucose; Brain; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Hypoglycemia; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Rats | 2007 |
Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users.
Topics: Adult; Brain Mapping; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Mental Recall; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Prefrontal Cortex; Temporal Lobe; Verbal Learning | 2013 |